STATIN SCAM

[Guest guest]

Found this in my NEXUS magazine

 

 

LOW CHOLESTEROL

INCREASES CANCER AND

DEATH RISK

In a major shot fired across the bow of the statin-drug marketing machine, the levels of LDL [ lipoprotein] cholesterol that are the artificial targets of health” promoted by the American Heart Association (AH have now been found to be associated with a significantly increased risk of and death.

 

The AHA recommends an LDL level of 100 for prevention and 70 for high-risk patients. In the new study an LDL level of I 07 was associated with a 33 per cent increased risk of cancer and death, and an LDL level of 87 was associated with a 50 per cent increased risk. As the LDL goes lower, the risk keeps getting worse. These arbitrary AHA levels for LDL cholesterol were established by “experts’ with direct financial ties to the statin industry, who knew full well that reaching their artificially low target levels for LDL would require double and triple doses of statin drugs, thus dramatically increasing sales (which has indeed happened).

 

This new study paints the clear picture that lowering LDL too low actually increases the rate of death from any cause. It also points out the statistical shenanigans that the statin drugs industry uses to hide the actual risks of these drugs in the studies that have been published.

 

There have been a number of studies in the past that link low cholesterol and cancer risk. However, these studies could not prove that the cancer was not already there prior to the start of the study—which has been the main argument used (besides statistical manipulation) by the statin industry to deny the association. In the new study, this issue was taken into account by eliminating participants with less than 2.5 years follow-up after the start of the study, thus demonstrating that the results were not due to pre-existing cancer.

 

Needless to say, this study was not part of the marketing machine propaganda that is rampant universities and ‘scientific’ journals that have been used to promote statin scams around the world, while actively blackmailing and blacklisting any authors, institutions or journals dare to step on Big Pharmas statin toes.

The study was published on August 2008 in the Canadian Medical Association Journal (CMAJ).

 

(Source: NaturalNews.com, August 2008, http://www.natural news.com/024001.html; the CMAJ article is at

http:I/www.cmaj .ca/cgi/ contentlfullll79/5/427)

OCTOBER — NOVEMBER 2008

www.nexusmagazine.com